# Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers

> **NCT00527150** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 48 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline Tartrate
- **DRUG:** Varenicline Tartrate
- **DRUG:** Varenicline Tartrate
- **DRUG:** Varenicline Tartrate
- **DRUG:** Varenicline Tartrate

## Key facts

- **NCT ID:** NCT00527150
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2010-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527150, "Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00527150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*